All Pharma News
Atea rejects `undervalued` offer from Concentra

Atea rejects `undervalued` offer from Concentra
James Waldron FIERCE BIOTECH
31 May 2023
Share Share
Atea confirms unsolicited cash proposal from Tang Capital’s Concentra

Atea confirms unsolicited cash proposal from Tang Capital’s Concentra
Kyle LaHucik ENDPTS
23 May 2023
Share Share
Concentra rebounds with a shot at COVID-19-focused Atea

Concentra rebounds with a shot at COVID-19-focused Atea
Annalee Armstrong FIERCE BIOTECH
22 May 2023
Share Share
Jounce Therapeutics Announces Closing of Tender Offer

Jounce Therapeutics Announces Closing of Tender Offer
GLOBENEWSWIRE
03 May 2023
Share Share
Termination of Proposed Business Combination of Jounce and Redx Pharma plc

Termination of Proposed Business Combination of Jounce and Redx Pharma plc
GLOBENEWSWIRE
03 Apr 2023
Share Share
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs

Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
HEALTH ET
28 Mar 2023
Share Share
Jounce Enters Into Agreement to Be Acquired by Concentra Biosciences

Jounce Enters Into Agreement to Be Acquired by Concentra Biosciences
GLOBENEWSWIRE
27 Mar 2023
Share Share
Jounce Announces Results from Data Review of INNATE Phase 2 Trial of JTX-8064

Jounce Announces Results from Data Review of INNATE Phase 2 Trial of JTX-8064
GLOBENEWSWIRE
16 Mar 2023
Share Share
Biotech makes surprise bid to snatch Jounce out of Redx’s hands

Biotech makes surprise bid to snatch Jounce out of Redx’s hands
James Waldron FIERCE BIOTECH
15 Mar 2023
Share Share
Jounce Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

Jounce Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
GLOBENEWSWIRE
14 Mar 2023
Share Share